このコーナーでは、L-FABP関連の論文を、慢性腎臓病（CKD）、急性腎障害（AKI）、Toxicology、Pharmacologyに分類し、紹介いたします。
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（文献リストの赤色の数字）を入力の上、ご連絡ください。

資料請求はこちら ▶

文献カテゴリー

慢性腎臓病（CKD）　急性腎障害（AKI）　薬剤性腎障害（Toxicology）
薬理学（Pharmacology）　運動（Exercise）　新型コロナウイルス感染症（COVID-19）　日本語総説　ガイドラインなど

慢性腎臓病（CKD） 【新着】

• 211 Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations. Sci Rep. 2023
  doi: 10.1038/s41598-023-38507-w PubMed
• 210 Association of urinary liver-type fatty acid-binding protein with outcomes after adrenalectomy for unilateral primary aldosteronism. Clin Chim　Acta.2023
  doi: 10.1016/j.cca.2023.117465. PubMed
• 207 Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia. Pregnancy Hypertens.2023
  doi: 10.1016/j.preghy.2023.02.001. PubMed
• 206 Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments. J Am Heart Assoc.2023
  doi: 10.1161/JAHA.122.028146. PubMed
• 205 Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients. Int Urol Nephrol.2023
  doi: 10.1007/s11255-023-03532-1. PubMed
• 203 Clinical utility of tubular markers in kidney disease: a narrative review. J Lab Precis Med.2022
  doi: 10.21037/jlpm-22-24 JLPM
• 200 Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis. Front Med (Lausanne).2022
  doi: 10.3389/fmed.2022.914587 PubMed

慢性腎臓病（CKD）関連文献の一覧へ ▶

急性腎障害（AKI） 【新着】

• 209 Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone. Nephrology (Carlton).2023
  DOI: 10.1111/nep.14162 PubMed
• 208 Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases. Care Explor. 2023
  doi: 10.1097/CCE.0000000000000873. PubMed
• 204 Evaluation of Urine L-FABP Point of Care Kit in the Philippines as Predictive Marker of Clinical Severity of COVID-19 (EPOCH COVID study). Philipp J Intern Med. 2022 PJIM
• 203 Clinical utility of tubular markers in kidney disease: a narrative review. J Lab Precis Med.2022
  doi: 10.21037/jlpm-22-24 JLPM
• 202 Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation. Clin Case Rep. 2022
  doi: 10.1002/ccr3.6531 PubMed
• 198 Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure. Heart Vessels. 2022
  doi: 10.1007/s00380-022-02174-0 PubMed
• 195 Early biomarkers for kidney injury inheat-related illness patients: a prospective observational study at Japanese Self-Defense Force FujiHospital. Nephrol Dial Transplant. 2022
  doi: 10.1093/ndt/gfac166. PubMed

急性腎障害（AKI）関連文献の一覧へ ▶

薬剤性腎障害（Toxicology） 【新着】

• 201 Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
  doi: 10.5455/OVJ.2022.v12.i6.12 PubMed
• 188 Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. BMC Nephrol.2022
  doi: 10.1186/s12882-022-02760-4. PubMed
• 184 Clinical Utility of a Biomarker to Detect Contrast-Induced AcuteKidney Injury during Percutaneous Cardiovascular Procedures. Cardiorenal Med.2022
  doi: 10.1159/000520820. PubMed
• 167 Changing trends in lipid profile and biomarkers of renalfunction and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofoviralafenamide: a prospective observational study. AIDS Res Ther.2021
  doi:10.1186/s12981-021-00354-y. PubMed
• 153 Early changes in tubular dysfunction markers and phosphorusmetabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleosideanalog therapy for chronic hepatitis B patients. Hepatol Res.2020
  doi:10.1111/hepr.13451. PubMed

薬剤性腎障害（Toxicology）関連文献の一覧へ ▶

薬理学（Pharmacology） 【新着】

• 206 Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments. J Am Heart Assoc.2023
  doi: 10.1161/JAHA.122.028146. PubMed
• 205 Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients. Int Urol Nephrol.2023
  doi: 10.1007/s11255-023-03532-1. PubMed
• 182 Tubular Injury Causing Protracted GlycosuriaFollowing Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in theDevelopment of Protracted Hypoglycemia and Ketoacidosis. Tohoku J ExpMed.2021
  doi: 10.1620/tjem.255.291. PubMed
• 179 Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition onBiomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized ControlledTrial. J Diabetes Res.2021
  doi: 10.1155/2021/7382620. PubMed

薬理学（Pharmacology）関連文献の一覧へ ▶

運動（Exercise） 【新着】

• 197 The moderate-intensity continuous exercise maintains renal blood flow and does not impair the renal function . Physiol Rep. 2022
  doi: 10.14814/phy2.15420. PubMed
• 194 Xanthine Oxidoreductase Activity in MarathonRunners: Potential Implications for Marathon-Induced Acute Kidney Injury. JAppl Physiol. 2022
  doi: 10.1152/japplphysiol.00669.2021. PubMed
• 181 Wearing a face mask during controlled-intensity exercise is nota risk factor for exertional heatstroke: A pilot study. Acute MedSurg.2021
  doi: 10.1002/ams2.712. PubMed
• 178 Exercise Ameliorates Diabetic Kidney Disease in Type 2 DiabeticFatty Rats. Antioxidants (Basel).2021
  doi: 10.3390/antiox10111754. PubMed
• 148 Effects of exercise on residual renal function in patientsundergoing peritoneal dialysis: a post-hoc analysis of a randomized controlled trial. Ther Apher Dial.2020
  PubMed

運動（Exercise）関連文献の一覧へ ▶

新型コロナウイルス感染症（COVID-19） 【新着】

• J49 当院での新型コロナウイルス感染症（COVID-19）入院患者から検討した重症化予測因子 内科2023
• 209 Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone. Nephrology (Carlton).2023
  DOI: 10.1111/nep.14162 PubMed
• 208 Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases. Care Explor. 2023
  doi: 10.1097/CCE.0000000000000873. PubMed
• 204 Evaluation of Urine L-FABP Point of Care Kit in the Philippines as Predictive Marker of Clinical Severity of COVID-19 (EPOCH COVID study). Philipp J Intern Med. 2022 PJIM
• J48 COVID－19と高血圧症・腎疾患 The Lipid33(1) 2022
• 192 Urine sediment findings were milder inpatients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renalinjuries. Int J Infect Dis. 2022
  doi: 10.1016/j.ijid.2022.02.024. PubMed
• 191 Direct hemoperfusion using a polymyxinB-immobilized polystyrene column for COVID-19. J Clin Apher. 2021
  doi:10.1002/jca.21861. PubMed
• 187 Metformin use in patients hospitalized withCOVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinicaloutcomes. J Thromb Thrombolysis. 2022
  doi: 10.1007/s11239-022-02631-7. PubMed
• 172 First Experience Addressing the PrognosticUtility of Novel Urinary Biomarkers in Patients With COVID-19. Open ForumInfect Dis. 2021
  doi: 10.1093/ofid/ofab274. PubMed
• 171 COVID-19-induced acute renal tubular injuryassociated with elevation of serum inflammatory cytokine. Clin Exp Nephrol.2021
  doi: 10.1007/s10157-021-02101-z. PubMed
• 155 Evaluation of Coronavirus Disease 2019Severity Using Urine Biomarkers. Crit Care Explor. 2020
  doi:10.1097/CCE.0000000000000170. PubMed

新型コロナウイルス感染症（COVID-19）一覧へ ▶

日本語総説 【新着】

• J49 当院での新型コロナウイルス感染症（COVID-19）入院患者から検討した重症化予測因子 内科2023
• J48 COVID－19と高血圧症・腎疾患 The Lipid33(1) 2022
• J47 【CKD 患者における抗がん薬治療】がん薬物療法前のAKIリスク評価とAKIバイオマーカー 腎と透析93(3) 2022
• J46 慢性腎臓病の重症化予防に向けた運動の役割 体力科学誌2019
• J45 習慣的な運動による老化関連疾患の予防 医学のあゆみ2018
• J44 SGLT2 阻害薬ルセオグリフロジンの腎機能障害合併2 型糖尿病患者に対する有用性の検討 診療と新薬55, 2018

日本語総説の一覧へ ▶

ガイドラインなど

一覧へ ▶

文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（下記リストの最初の数字）を入力の上、ご連絡ください。

資料請求はこちら ▶

文献カテゴリー

慢性腎臓病（CKD）　急性腎障害（AKI）　薬剤性腎障害（Toxicology）
薬理学（Pharmacology）　運動（Exercise）　新型コロナウイルス感染症（COVID-19）　日本語総説　ガイドラインなど